Nakagawa M - Search Results

1

Cerebral metabolic changes in early multiple system atrophy: a PET study.

Taniwaki T, Nakagawa M, Yamada T, Yoshida T, Ohyagi Y, Sasaki M, Kuwabara Y, Tobimatsu S, Kira J. Taniwaki T, et al. Among authors: nakagawa m. J Neurol Sci. 2002 Aug 15;200(1-2):79-84. doi: 10.1016/s0022-510x(02)00151-x. J Neurol Sci. 2002. PMID: 12127681

2

PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism.

Nakagawa M, Kuwabara Y, Taniwaki T, Sasaki M, Koga H, Kaneko K, Hayashi K, Kira J, Honda H. Nakagawa M, et al. Ann Nucl Med. 2005 Jun;19(4):267-75. doi: 10.1007/BF02984618. Ann Nucl Med. 2005. PMID: 16097635 Clinical Trial.

3

Cerebral blood flow and vasodilatory capacity in anemia secondary to chronic renal failure.

Kuwabara Y, Sasaki M, Hirakata H, Koga H, Nakagawa M, Chen T, Kaneko K, Masuda K, Fujishima M. Kuwabara Y, et al. Among authors: nakagawa m. Kidney Int. 2002 Feb;61(2):564-9. doi: 10.1046/j.1523-1755.2002.00142.x. Kidney Int. 2002. PMID: 11849397 Free article.

4

The usefulness of dipyridamole thallium-201 single photon emission computed tomography for predicting perioperative cardiac events in patients undergoing non-cardiac vascular surgery.

Chen T, Kuwabara Y, Tsutsui H, Sasaki M, Nakagawa M, Koga H, Kaneko K, Komori K, Masuda K. Chen T, et al. Among authors: nakagawa m. Ann Nucl Med. 2002 Feb;16(1):45-53. doi: 10.1007/BF02995291. Ann Nucl Med. 2002. PMID: 11922208

5

11C-methionine uptake in cerebrovascular disease: a comparison with 18F-fDG PET and 99mTc-HMPAO SPECT.

Nakagawa M, Kuwabara Y, Sasaki M, Koga H, Chen T, Kaneko O, Hayashi K, Morioka T, Masuda K. Nakagawa M, et al. Ann Nucl Med. 2002 May;16(3):207-11. doi: 10.1007/BF02996302. Ann Nucl Med. 2002. PMID: 12126046

6

Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.

Sasaki M, Kuwabara Y, Koga H, Nakagawa M, Chen T, Kaneko K, Hayashi K, Nakamura K, Masuda K. Sasaki M, et al. Among authors: nakagawa m. Ann Nucl Med. 2002 Jul;16(5):337-45. doi: 10.1007/BF02988618. Ann Nucl Med. 2002. PMID: 12230093 Clinical Trial.

7

Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer.

Sasaki M, Sugio K, Kuwabara Y, Koga H, Nakagawa M, Chen T, Kaneko K, Hayashi K, Shioyama Y, Sakai S, Honda H. Sasaki M, et al. Among authors: nakagawa m. Ann Nucl Med. 2003 May;17(3):189-96. doi: 10.1007/BF02990021. Ann Nucl Med. 2003. PMID: 12846540 Clinical Trial.

8

Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.

Koga H, Matsuo Y, Sasaki M, Nakagawa M, Kaneko K, Hayashi K, Kuwabara Y, Honda H. Koga H, et al. Among authors: nakagawa m. Ann Nucl Med. 2003 Jun;17(4):327-31. doi: 10.1007/BF02988530. Ann Nucl Med. 2003. PMID: 12932118

9

An analysis of the physiological FDG uptake pattern in the stomach.

Koga H, Sasaki M, Kuwabara Y, Hiraka K, Nakagawa M, Abe K, Kaneko K, Hayashi K, Honda H. Koga H, et al. Among authors: nakagawa m. Ann Nucl Med. 2003 Dec;17(8):733-8. doi: 10.1007/BF02984984. Ann Nucl Med. 2003. PMID: 14971621 Clinical Trial.

10

Validation of the CBF, CBV, and MTT values by perfusion MRI in chronic occlusive cerebrovascular disease: a comparison with 15O-PET.

Kaneko K, Kuwabara Y, Mihara F, Yoshiura T, Nakagawa M, Tanaka A, Sasaki M, Koga H, Hayashi K, Honda H. Kaneko K, et al. Among authors: nakagawa m. Acad Radiol. 2004 May;11(5):489-97. doi: 10.1016/S1076-6332(03)00722-0. Acad Radiol. 2004. PMID: 15147613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,040 results

Search Page

Filters